Gilenya : Précautions et recommandation d’utilisation lors de l’initiation du traitement

Mis à jour par Phel · hier à 07:32 · Version 1.1874

Document Adobe Acrobat PDF (284.24 Ko)

Document ENNOV Neurologie

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